Bork, K <br/><br/>
Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII).  [electronic resource] 

 -  Allergy  Feb 2017 
 - 320-324 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1398-9995 
<br/><br/><label>Standard No.: </label>10.1111/all.13076  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Angiotensin-Converting Enzyme Inhibitors--adverse effects<br/>Biomarkers<br/>Chemoprevention<br/>Child<br/>Complement C1 Inhibitor Protein--therapeutic use<br/>Disease Progression<br/>Estrogens--adverse effects<br/>Factor XII--genetics<br/>Female<br/>Hereditary Angioedema Type III--blood<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation<br/>Risk Factors<br/>Treatment Outcome<br/>Young Adult